Current glycemic status and diabetes related complications among type 2 diabetes patients in India: Data from the A1chieve study

Journal of Association of Physicians of India

Volumn 61, Issue SPL. 1, 2013, Pages 12-15

  Mohan, Viswanathan ^a   Shah, Siddharth ^b   Saboo, Banshi ^c  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

^b Bhatia Hospital   (India)

^c Dia Care Clinic   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD; DIABETIC ANGIOPATHY; DIABETIC FOOT; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; EYE DISEASE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INDIA; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PROSPECTIVE STUDY;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC FOOT; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; EYE DISEASES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INDIA; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES;

EID: 84875139223     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Whiting DR, Guariguata L, Weil C, Shaw J. IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011;94:311-21.
2. Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, et al. On behalf of the ICMR-INDIAB Collaborative Study Group. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: Phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia 2011;54:3022-7.
3. R ema M, Premkumar S, Anitha B, Deepa R, Pradeepa R, Mohan V. Prevalence of diabetic retinopathy in urban India: The Chennai Urban Rural Epidemiology Study (CURES) Eye Study I. Invest Ophthalmol Vis Sci 2005;46:2328-2333.
4. U nnikrishnan RI, Rema M, Pradeep R, Deepa M, Shanthirani, CS, Deepa R, Mohan V. Prevalence and risk factor of diabetic nephropathy in an urban south Indian population; The Chennai Urban Rural Epidemiology study (CUR ES-45). Diabetes Care 2007;30:2019-2024.
5. Pradeepa R, Rema M, Vignesh J, Deepa M, Deepa R, Mohan V. Prevalence and risk factors for diabetic neuropathy in an urban south Indian population: The Chennai Urban Rural Epidemiology Study (CURES-55). Diabet Med 2008;25:407-412.
6. Mohan V, Deepa R, Shanthi Rani S, Premalatha G. Prevalence of coronary artery disease and its relationship to lipids in a selected population in south India. Journal of American College of Cardiology 2001;38:682-687.
7. Premalatha G, Shanthi Rani CS, Deepa R, Markovitz J, Mohan V. Prevalence and risk factors of peripheral vascular disease in a selected south Indian population-The Chennai Urban Population Study (CUPS). Diabetes Care 2000;23:295-1300.
8. Tharkar S, Devarajan A, Kumpatla S, Viswanathan V. The socioeconomics of diabetes from a developing country: a population based cost of illness study. Diabetes Res Clin Pract 2010;89:334-40.
9. Kohner EM, Aldington SJ, Stratton IM, et al. Diabetic retinopathy at diagnosis of non insulin dependent diabetes mellitus and associated risk factors. United Kingdom Prospective Diabetes Study, 30. Arch Ophthalmology 1998;116:297-303.
10. The Diabetes Control and Complications Trial Research Group. Clustering of long-term complications in families with diabetes in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. Diabetes 1997;46:1829-1839.
11. Home P, Naggar NE, Khamseh M, Gonzalez-Galvez G, Shen C, Chakkarwar P, et al. An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: the A1chieve® study. Diabetes Res Clin Pract 2011;94:352-63.
12. Coates PA, Ollerton RL, Luzio SD, Ismail I, Owens DR. A glimpse of the 'natural history' of established type 2 (non-insulin dependent) diabetes mellitus from the spectrum of metabolic and hormonal responses to a mixed meal at the time of diagnosis. Diabetes Res Clin Pract 1994;26:177-87.
13. Meier JJ Beta cell mass in diabetes: a realistic therapeutic target? Diabetologia 2008;51:703-13.
14. Turner RC, Cull CA, Frighi V, Holman RR, UK Prospective Diabetes Study (UKPDS) Group. Glycaemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA 1999;281:2005-12.
15. Wright A, Burden AC, Paisey RB, Cull CA, Holman RR, for the UK Prospective Diabetes Study Group. Sulfonylurea inadequacy. Efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the UK Prospective Diabetes Study (UKPDS 57). Diabetes Care 2002;25:330-6.
16. Davies M. The reality of glycaemic control in insulin treated diabetes: defining the clinical challenges. Int J Obes Relat Metab Disord 2004;28(Suppl. 2):S14-22.
17. Luddeke HJ, Sreenan S, Aczel S, Maxeiner S, Yenigun M, Kozlovski P, et al. PREDICTIVE-a global, prospective observational study to evaluate insulin detemir treatment in types 1 and 2 diabetes: baseline characteristics and predictors of hypoglycaemia from the European cohort. Diabetes Obes Metab 2007;9:428-34.
18. Valensi P, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, et al. The IMPROVE study-a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts. Int J Clin Pract 2008;62:1809-19.
19. R askin P, Allen E, Hollander P, et al. for the INITIATE Study Group. Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs. Diabetes Care 2005;28:260-5.
20. Shah S, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, et al. Safety and effectiveness of biphasic insulin aspart 30/70 (NovoMix_30) when switching from human premix insulin in patients with type 2 diabetes: subgroup analysis from the 6-month IMPROVETM observational study. Int J Clin Pract 2009;63:522-31.
21. Mohan V. et al. Current Status of Management of Diabetes and Glycaemic Control in India: Preliminary Results from the DiabCare India 2011 Study. Diabetes 2012;61:A645-A677 [2634-PO].
22. Berlowitz DR, Ash AS, Glickman M, Friedman RH, Pogach LM, Nelson AL, et al. Developing a Quality of Measure for Clinical Inertia in Diabetes Care. Health Serv Res 2005;40:1836-53.
23. Deepa M, Deepa R, Shanthirani CS, Datta M, Unwin NC, Kapur A, et al Awareness and knowledge of diabetes in Chennai-the Chennai Urban Rural Epidemiology Study [CURES-9]. J Assoc Physicians India 2005;53:283-7.